China Pharma (CPHI) Stock: Buy, Sell, or Hold?
$0.54
-0.01 (-1.43%)
▼
5d:
-7.56%
30d:
-27.72%
90d:
-50.17%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (58%)
Quality Score
52/100
Position
OVERSOLD
30-Day Fair Range
$0.57 – $0.78
Position: OVERSOLD
Forward P/E & Valuation
1.6x
Next 12M consensus est.
Wall Street Target
$3.00
+452.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.50 / $0.68
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CPHI shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When CPHI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CPHI is currently trading at $0.54, which is considered oversold relative to its 30-day fair value range of $0.57 to $0.78.
Technical Outlook: Technically, CPHI is showing sideways momentum. Immediate support is located at $0.50, while resistance sits at $0.68.
Market Sentiment: CPHI scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.00 (+452.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CPHI is showing sideways momentum. Immediate support is located at $0.50, while resistance sits at $0.68.
Market Sentiment: CPHI scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.00 (+452.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.57 -
$0.78
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Trading Range & Key Levels
30-Day Trading Range
$0.57 -
$0.78
Current vs Trading Range
OVERSOLD
Support Level
$0.50
Resistance Level
$0.68
Current Trend
Sideways
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 452.4% below Wall St target ($3.00)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
1.56
Wall Street Target
$3.00
(+452.4%)
Revenue Growth (YoY)
-7.5%
Profit Margin
-114.3%
Share CPHI Analysis
Share this live CPHI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CPHI)
Neutral
2 Retail Mentions
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Oct 29, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits is currently filled with bullish sentiment towards $CPHI, with traders expressing optimism about recent performance and the outlook for ICMB. No significant news articles were identified.
Key Retail Themes:
Positive sentiment towards $CPHI and ICMB
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:58 PM ET
Data refreshes hourly during market hours. Next update: 9:58 PM
Data refreshes hourly during market hours. Next update: 9:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CPHI showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 33 SELL |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$687 | 52 HOLD |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 53 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CPHI Research Pages
